They allow us to improve your browsing experience and analyze website traffic. Analytics cookies are used only with your consent. Read our Privacy Policy.
Preimplantation Genetic Testing of Embryos
Last updated
Understanding Preimplantation Genetic Testing
Preimplantation Genetic Testing (PGT) refers to genetic testing performed on cells from embryos created through IVF before an embryo is selected for transfer. Depending on the medical indication, testing may assess chromosome number, a known inherited single-gene condition or a structural chromosome rearrangement.

Genetic testing can provide useful information in selected circumstances, but it is important to understand the purpose and limitations of each test before deciding whether to proceed.
The Main Types of PGT
PGT-A – Testing for Aneuploidy
PGT-A assesses whether an embryo appears to have the expected number of chromosomes. A typical human embryo has 46 chromosomes arranged in 23 pairs. An embryo with an extra or missing chromosome is described as aneuploid.
PGT-A is intended to help identify embryos with chromosome-number findings that may affect implantation, miscarriage risk or the likelihood of certain chromosome conditions. It does not test every gene or rule out every genetic or developmental condition.
PGT-M – Testing for a Monogenic Condition
PGT-M is designed for families with a known risk of a specific inherited condition caused by a change in a single gene. Testing is planned around the identified genetic variant and usually requires preparation by a genetics laboratory before the IVF cycle.
Examples may include selected inherited conditions such as cystic fibrosis or spinal muscular atrophy, when the relevant familial genetic risk has been established. The exact test is condition-specific.
PGT-SR – Testing for Structural Chromosome Rearrangements
PGT-SR may be considered when a genetic parent carries a known structural chromosome rearrangement, such as a translocation. The test is designed to identify embryos with relevant unbalanced chromosome findings associated with that rearrangement.
How Is Embryo Testing Performed?
In many IVF programs, embryos are cultured to the blastocyst stage, usually around day 5 or 6 of development. A small number of cells are taken from the trophectoderm, the cell layer that normally contributes to the placenta. The biopsy is sent to a specialized genetics laboratory for analysis.
Embryos are commonly cryopreserved while the laboratory performs the test. Once the results are available, the fertility specialist and, where appropriate, a genetic counselor discuss the findings and possible next steps.
Understanding the Results
Depending on the test and laboratory, results may be reported as consistent with a normal chromosome result (often called euploid), an abnormal chromosome result (aneuploid), a mosaic result, or no result/inconclusive.
A mosaic result means that the biopsy sample showed a mixture of cells with different chromosome findings. The interpretation and possible use of a mosaic embryo require specialist genetic and reproductive counseling. Laboratory thresholds and reporting practices can differ.
Does PGT Guarantee a Healthy Baby?
No. PGT is not a guarantee of implantation, an ongoing pregnancy or the birth of a healthy child. The biopsy examines a small sample of cells and may not perfectly represent every cell in the embryo. False-positive, false-negative, mosaic or inconclusive results can occur.
PGT does not screen for every genetic condition, birth defect or developmental difference. A PGT-A result does not replace all prenatal screening or diagnostic options during pregnancy.
Is PGT-A Necessary for Every IVF Cycle?
No. PGT-A is not automatically required for every IVF or surrogacy program. Evidence about its benefits varies according to patient circumstances, age, embryo number, medical history and treatment goals. It should not be presented as a universal test that improves the outcome for every patient.
The decision should be made with the fertility specialist after discussing the potential benefits, limitations, costs and possible outcomes, including what the clinic would recommend if a result is mosaic or inconclusive.
Older Terms: PGD and PGS
Older clinic materials may use the terms PGD (preimplantation genetic diagnosis) or PGS (preimplantation genetic screening). Current terminology generally uses PGT, with the type of testing specified as PGT-A, PGT-M or PGT-SR.
A description such as '24-chromosome testing' usually refers to chromosome-level assessment; it does not mean that every gene in the embryo has been sequenced or that all genetic conditions have been excluded.
Prenatal Testing After PGT
Even after PGT, intended parents should discuss prenatal screening and diagnostic testing with the obstetrician or genetic specialist once pregnancy is established. The options may include ultrasound, NIPT, chorionic villus sampling or amniocentesis, depending on the circumstances and the patient's informed choice.
Sources
Contact New Hope
New Hope can help coordinate communication with the fertility clinic when genetic testing is being considered. The decision about which test is appropriate must be made with the treating fertility specialist and, when needed, a genetic counselor.